These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18578327)

  • 1. [The technological progress in haemodialysis: potassium profiling].
    Kes P; Racki S; Basić-Jukić N; Ratković-Gusić I
    Acta Med Croatica; 2008; 62 Suppl 1():12-6. PubMed ID: 18578327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with complex arrhythmias during and after haemodialysis suffer from different regimens of potassium removal.
    Santoro A; Mancini E; London G; Mercadal L; Fessy H; Perrone B; Cagnoli L; Grandi E; Severi S; Cavalcanti S
    Nephrol Dial Transplant; 2008 Apr; 23(4):1415-21. PubMed ID: 18065796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of acetate-free biofiltration with a potassium-profiled dialysate on the control of cardiac arrhythmias in patients at risk: a pilot study.
    Muñoz RI; Montenegro J; Salcedo A; Gallardo I; Martínez I; Quintanilla N; Saracho R; Lekuona I
    Hemodial Int; 2008 Jan; 12(1):108-13. PubMed ID: 18271851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal composition of the dialysate, with emphasis on its influence on blood pressure.
    Locatelli F; Covic A; Chazot C; Leunissen K; Luño J; Yaqoob M
    Nephrol Dial Transplant; 2004 Apr; 19(4):785-96. PubMed ID: 15031331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The technological progress in haemodialysis: on-line hemodiafiltration].
    Racki S; Kes P; Basić-Jukić N
    Acta Med Croatica; 2008; 62 Suppl 1():44-8. PubMed ID: 18578332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potassium level changes--arrhythmia contributing factor in chronic kidney disease patients.
    Checheriţă IA; David C; Diaconu V; Ciocâlteu A; Lascăr I
    Rom J Morphol Embryol; 2011; 52(3 Suppl):1047-50. PubMed ID: 22119823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Haemodialysis - the current practice].
    Nedbálková M
    Vnitr Lek; 2011; 57(7-8):640-4. PubMed ID: 21877599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ECG manifestations of selected metabolic and endocrine disorders.
    Wald DA
    Emerg Med Clin North Am; 2006 Feb; 24(1):145-57, vii. PubMed ID: 16308117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrhythmias and sudden cardiac death in hemodialysis patients. Temporal profile, electrolyte abnormalities, and potential targeted therapies.
    Epstein M; Roy-Chaudhury P
    Nephrol News Issues; 2016 Apr; 30(4):suppl 23-6. PubMed ID: 27254902
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cardiac arrhythmias in patients with renal insufficiency treated with periodic hemodialysis].
    Santoro A; Basile C
    G Ital Nefrol; 2006; 23(6):552-9. PubMed ID: 17173261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of cardiac arrhythmias in hemodialysis: what are the modulating factors?].
    Nowak G; El Housseini Y; Tataw Ashu J; Teta D
    Rev Med Suisse; 2015 Feb; 11(463):505-10. PubMed ID: 25898459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potassium balance in dialysis patients.
    Sanghavi S; Whiting S; Uribarri J
    Semin Dial; 2013; 26(5):597-603. PubMed ID: 24073843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac arrhythmias and electrolyte changes during haemodialysis.
    Rombolà G; Colussi G; De Ferrari ME; Frontini A; Minetti L
    Nephrol Dial Transplant; 1992; 7(4):318-22. PubMed ID: 1317522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiopathology of cardiac arrhythmias in end-stage renal disease.
    Strata G; Limbruno U; Leoncini GP; Di Vincenzo A; Palla R; Mariani M
    Contrib Nephrol; 1994; 106():30-5. PubMed ID: 8174374
    [No Abstract]   [Full Text] [Related]  

  • 15. [Technical advances in haemodialysis].
    Mercadal L; Petitclerc T
    Nephrol Ther; 2009 Apr; 5(2):109-13. PubMed ID: 19013119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sodium and potassium content of erythrocytes at the terminal stage of chronic renal insufficiency and during treatment by chronic hemodialysis].
    Terekhov NT; Goligorskiĭ MS; Kremen' MG; Vasilenko VK
    Urol Nefrol (Mosk); 1974; (6):10-4. PubMed ID: 4141153
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased coated-platelet levels in chronic haemodialysis patients.
    Valaydon ZS; Lee P; Dale GL; Januszewski AS; Rowley KG; Nandurkar H; Karschimkus C; Best JD; Lyons TJ; Jenkins AJ
    Nephrology (Carlton); 2009 Apr; 14(2):148-54. PubMed ID: 19076292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
    Nüsken KD; Petrasch M; Rauh M; Stöhr W; Nüsken E; Schneider H; Dötsch J
    Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients.
    Okuno S; Ishimura E; Kohno K; Fujino-Katoh Y; Maeno Y; Yamakawa T; Inaba M; Nishizawa Y
    Nephrol Dial Transplant; 2009 Feb; 24(2):571-7. PubMed ID: 18799606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute decrease in plasma potassium concentration following intravenous mannitol as a result of hemodilution in stable chronic hemodialysis patients.
    Swan AM; DeVita MV; Michelis MF
    Clin Nephrol; 1997 Apr; 47(4):276-7. PubMed ID: 9128799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.